Highlights
1 patentProfile claimed by owner
About
Fast-lane Cancer Monitoring and Screening
Infiniplex's mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at an accessible and affordable cost. The company's goal is to identify common and rare cancer types through a standard, inexpensive blood test that could be carried out as part of routine checkups, leveraging existing laboratory equipment and know-how. Infiniplex aims to include tumor genomic testing as part of people's standard blood test checkups.
Identity
| Name | Infiniplex |
|---|---|
| Slug | infiniplex |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJzVgc0IDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Yokne'am Illit |
| HQ address | Yokne'am Illit, Israel |
Web & social
| Website | https://infiniplex.life |
|---|---|
| https://www.linkedin.com/company/90814003 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMoleculesGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesMedical Devices IndustryHealthcareProviders
Business models
B2B
Tags
screeningbiomarkerscancer-diagnosticsmachine-learningmonitoringhealthcarebiotechnologyoncologydiagnosticscancermedical-technologiesgeneticsbioinformatics
Funding
| Total raised | $1.1M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}